Research Topics
| David R CornblathSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Recent advances in HIV neuropathyDavid R Cornblath
School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
Curr Opin Neurol 19:446-50. 2006..To describe recent advances in HIV neuropathy...
National Institute of Neurological Disorders and Stroke (NINDS): advances in understanding and treating neuropathy, 24-25 October 2006; Bethesda, MarylandEva L Feldman
Department of Neurology, University of Michigan, Ann Arbor, MI 48109 2200, USA
J Peripher Nerv Syst 13:1-6. 2008..Short-term goals of the workshop were to form a working group for neuropathy, the Peripheral Neuropathy Study Group, and to translate new scientific findings into therapies and complete clinical trials...
The safety profile of dalfampridine extended release in multiple sclerosis clinical trialsDavid R Cornblath
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Clin Ther 34:1056-69. 2012..Dalfampridine extended-release tablets have been approved by the US Food and Drug Administration to improve walking in patients with multiple sclerosis (MS)...- Surgical decompression for diabetic sensorimotor polyneuropathyDavid R Cornblath
Department of Neurology, Johns Hopkins Hospital, Baltimore, MD 21287, USA
Diabetes Care 30:421-2. 2007 - An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathyVinay Chaudhry
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
J Peripher Nerv Syst 15:196-201. 2010..We conclude that rituximab can be safely given to people with MMN but in this pilot study we were unable to reduce the amount of IVIg required, at least in the regimen used... - Worsening of multifocal motor neuropathy during pregnancyVinay Chaudhry
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Neurology 59:139-41. 2002..All were treated with IV immunoglobulin during pregnancy and improved in strength. After pregnancy, strength in all patients returned to the prepregnancy state. The authors conclude that pregnancy may worsen MMN... - Peripheral nerve vasculitis presenting as complex regional pain syndromeSindhu Ramchandren
Department of Neurology, Wayne State University, Detroit Medical Center, University Health Center 8C20, Detroit, MI 48201, USA
J Clin Neuromuscul Dis 10:61-4. 2008..To report the clinical, electrodiagnostic, and pathologic findings in 3 patients who presented with complex regional pain syndrome as their primary manifestation of peripheral nerve vasculitis... - Peripheral neuropathies in human immunodeficiency virus infectionAhmet Hoke
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Suppl Clin Neurophysiol 57:195-210. 2004 - A framework for diagnosing and classifying intensive care unit-acquired weaknessRobert D Stevens
Division of Neurosciences Critical Care, Department of Anesthesiology Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Crit Care Med 37:S299-308. 2009..We propose a simple framework for diagnosing and classifying neuromuscular disorders acquired in critical illness... - Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practiceKenneth C Gorson
Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
J Peripher Nerv Syst 15:326-33. 2010..0001). The CDAS is considered a simple and reproducible tool to classify patients with CIDP according to disease activity and treatment status that can be applied easily in practice and potentially to select patients for clinical trials... - Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric propertiesKathleen A Griffith
Department of Organizational Systems and Adult Health, University of Maryland School of Nursing, Baltimore, MD 21201, USA
J Peripher Nerv Syst 15:314-25. 2010..However, to improve QUADAS scoring, additional research is needed focusing on other psychometric aspects such as responsiveness of CIPN outcome measures... - Characteristics of bortezomib- and thalidomide-induced peripheral neuropathyVinay Chaudhry
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
J Peripher Nerv Syst 13:275-82. 2008..In a subset, a more severe demyelinating polyneuropathy may develop... - Perioperative bilateral median neuropathyGiorgia Melli
Johns Hopkins Hospital, Johns Hopkins School of Medicine, Baltimore, MD 21287-7681, USA
Anesthesiology 97:1632-4. 2002 - Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutationScott D Z Eggers
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Muscle Nerve 29:867-9. 2004..This report furthers the understanding of the clinical and electrophysiological manifestations of MPZ mutations... - Guillain-Barré syndromeRichard A C Hughes
Department of Clinical Neuroscience, King s College London School of Medicine, Guy s Hospital, UK
Lancet 366:1653-66. 2005..Further research is needed to discover treatments to prevent 20% of patients from being left with persistent and significant disability...